References
- Allison, A.C. and Byars, N.E. (1992a) “Immunological adjuvants”, Adv. Exp. Med. Biol. 327, 133–141.
- Allison, A.C. and Byars, N.E. (1992b) “Syntex adjuvant formulation”, Res. Immunol. 143, 519–525.
- Bozkir, A. and Hayta, G. (2003) “Preparation and in vitro evaluation of multiple (w/o/w) emulsions containing ınfluenza virus antigen”, Proceedings 7th International Symposium on Pharmaceutical Sciences, 24-27 June, p:237, Ankara.
- Chattaraj, S.C., Rathinavelu, A. and Das, S.K. (1999) “Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice”, J. Control. Rel. 58, 223–232.
- Dryer, R.L. and Lata, G.F. (1989) “Electrokinetic phenomena. experimental biochemistry”, (Oxford University Press), pp 144–151.
- Floyd, A.G. (1999) “Top ten considerations in the development of parenteral emulsions”, PTTS 2(4),134–143.
- Hilbert, A.K., Fritzsche, U. and Kissel, T. (1999) “Biodegradable microspheres containing influenza A vaccine: immune response in mice”, Vaccine 17, 1065–1073.
- Hilgers, L.A.T., Platenburg, P.L.I., Luitjens, A., Groenveld, B., Dazelle, T., Laloux, M.F. and Weststrate, M.W. (1994a) “A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals”, Vaccine 12(7),653–660.
- Hilgers, L.A.T., Platenburg, P.L.I., Luitjens, A., Groenveld, B., Dazelle, T. and Weststrate, M.W. (1994b) “A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs”, Vaccine 12(7),661–665.
- Hilgers, L.A.T., Lejeune, G., Nicolas, I., Fochesato, M. and Boon, B. (1999) “Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant”, Vaccine 17, 219–228.
- Ison, M.G. and Hayden, F.G. (2001) “Therapeutic options for the management of influenza”, Curr. Opin. Pharmacol. 1, 482–490.
- Law, T.K., Whateley, T.L. and Florence, A.T. (1986) “Stabilization of W/O/W multiple emulsions by interfacial complexation of macro- molecules and nonionic surfactants”, J. Control. Rel. 3, 279–290.
- Lemonie, D. and Preat, V. (1998) “Polymeric nanoparticles as delivery system for influenza virus glycoproteins”, J. Control. Rel. 54, 15–27. Mishra, B. and Pandit, J.K. (1990) “Multiple water-oil-water emulsions as prolonged release formulations of pentazocine”, J. Control. Rel. 14, 53–60.
- O’Hagan, D.T., Mackichan, M.L. and Singh, M. (2001) “Recent developments in adjuvants for vaccines against infectious diseases”, Biomol. Eng. 18, 69–85.
- Okochi, H. and Nakano, M. (1997) “Comparative study of two preparation methods of w/o/w emulsions: stirring and membrane emulsification”, Chem. Pharm. Bull. 45(8),1323–1326.
- Okochi, H. and Nakano, M. (2000) “Preparation and evaluation of w/o/w type emulsions containing vancomycin”, Adv. Drug Deliv. Rev. 45, 5–26.
- Omotosho, J.A., Whateley, T.L. and Florence, A.T. (1989) “Methotrexate transport from the internal phase of multiple w/o/w emulsions”, J. Microencapsul. 6(2),183–192.
- Podda, A. (2001) “The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine”, Vaccine 19, 2673–2680.
- Rimmelzwaan, G.F. and Osterhaus, A.D.M.E. (2001) “Influenza vaccines: new developments”, Curr. Opin. Pharmacol. 1, 491–496. Smith, P.K., Krown, R.I., Hermonson, G.T., Gartner, G.T., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. and Klenk, D.C. (1985) “Measurement of protein using bicinchoninic acid”, Anal. Biochem. 150, 76–85.
- Spiers, I.D., Alpar, H.O., Eyles, J.E., Bozkir, A., Miller, J. and Williamson, E.D. (1999) “Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis”, J. Pharm. Pharmacol. 51, 991–997.
- Switzer, R.C., Merril, C.R. and Shifrin, S. (1979) “A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels”, Anal. Biochem. 98, 231–237.
- U.S. Department of health, education and welfare (1975) “Hemagglutina- tion Inhibition Test. Advanced laboratory techniques for influenza diagnosis”, Public Health Serv, 25–62.
- Yannarell, D.A., Goldberg, K.M. and Hjorth, R.N. (2002) “Stabilizing cold-adapted influenze virus vaccine under various storage conditions”, J. Virol. Meth. 102, 15–25.
- Wilde, J.A., Mcmillan, J.A., Serwint, J., Butta, J., O’riordan, M.A. and Steinhoff, M.C. (1999) “Effectiveness of influenza vaccine in health care professionals”, JAMA 281(10),908–913.